Canadian Journal of Anesthesia, Vol 44, 208-215, Copyright © 1997 by Canadian Anesthesiologists' Society

ARTICLES

Spinal anaesthesia with midazolam in the rat

M Bahar, ML Cohen, Y Grinshpon and M Chanimov
Department of Anaesthesiology, Assaf Harofeh, Medical Centre, Zerifin, Israel.

PURPOSE: This study examined in an animal model whether intrathecal midazolam, alone or with fentanyl, can achieve anaesthesia sufficient for laparotomy, comparable to lidocaine. Effects on consciousness and whether anaesthesia was segmental were also examined. The haemodynamic and respiratory changes were compared with those of intrathecal lidocaine or intrathecal fentanyl alone. METHODS: Sixty Wistar strain rats, with nylon catheters chronically implanted in the lumbar subarachnoid theca, were divided into six groups. Group 1 (n = 12) received 75 microL intrathecal lidocaine 2%. Group 2 (n = 12) received 75 microL intrathecal midazolam 0.1%, Group 3 (n = 12) received intrathecal 37.5 microL midazolam 0.1%, plus 37.5 microL fentanyl 0.005%. Group 4 (n = 12) received intrathecal 50 microL fentanyl 0.005%. Group 5 (n = 6) received 75 microL midazolam 0.1% iv. Group 6 (n = 6) received halothane 0.6% in oxygen by inhalation. RESULTS: Both groups that received intrathecal midazolam, alone or combined with fentanyl, developed effective segmental sensory and motor blockade of the hind limbs and abdominal wall, sufficient for a pain-free laparotomy procedure. Neither of these groups, unlike the group that received intrathecal lidocaine, developed a reduction in blood pressure or change in heart rate at the time of maximal sensory or motor blockade, nor were there changes in the arterial blood gases or respiratory rate. CONCLUSION: Midazolam, when injected intrathecally, produces reversible, segmental, spinally mediated antinociception, sufficient to provide balanced anaesthesia for abdominal surgery.

This article has been cited by other articles:

				T. L. Yaksh and J. W. Allen Preclinical Insights into the Implementation of Intrathecal Midazolam: A Cautionary Tale Anesth. Analg., June 1, 2004; 98(6): 1509 - 1511. [Full Text] [PDF]

				T. Nishiyama and K. Hanaoka Midazolam Can Potentiate the Analgesic Effects of Intrathecal Bupivacaine on Thermal- or Inflammatory-Induced Pain Anesth. Analg., May 1, 2003; 96(5): 1386 - 1391. [Abstract] [Full Text] [PDF]

				P. N. Gueye, S. W. Borron, P. Risede, C. Monier, F. Buneaux, M. Debray, and F. J. Baud Buprenorphine and Midazolam Act in Combination to Depress Respiration in Rats Toxicol. Sci., January 1, 2002; 65(1): 107 - 114. [Abstract] [Full Text] [PDF]

				T. Nishiyama, L. Gyermek, C. Lee, S. Kawasaki-Yatsugi, and T. Yamaguchi Synergistic analgesic effects of intrathecal midazolam and NMDA or AMPA receptor antagonists in rats Can J Anesth, March 1, 2001; 48(3): 288 - 294. [Abstract] [Full Text] [PDF]

				T. Nishiyama, T. Matsukawa, and K. Hanaoka Acute Phase Histopathological Study of Spinally Administered Midazolam in Cats Anesth. Analg., September 1, 1999; 89(3): 717 - 717. [Abstract] [Full Text] [PDF]